<h1>Mirae Asset Sells Shares in Gland Pharma Ltd, Reducing Stake Through Open Market Transaction</h1>
Mirae Asset Mutual Fund has sold a portion of its holding in Gland Pharma Limited through the open market. The transaction was completed on July 13, 2026, as part of the ongoing shareholding adjustments for the investor.
The sale impacted Mirae Asset Mutual Fund’s stake in the company. Before the disposition, the fund held 8,511,810 shares carrying voting rights, representing a holding of 5.17% to 5.14%.
The transaction details and the changes in the investment portfolio are summarized below:
| Metric | Before Sale Holdings | Transaction Details | After Sale Holdings |
|---|---|---|---|
| Shares Carrying Voting Rights | 8,511,810 | -300,972 shares (representing -0.18%) sold in Open Market | 8,210,838 |
| Holding Percentage (approx.) | 5.14% to 5.17% | N/A | 4.96% to 4.98% |
The sale was conducted through the open market mechanism on July 13, 2026. Following the disposition of these shares, Mirae Asset Mutual Fund’s total holding of shares carrying voting rights in Gland Pharma Limited stands at 8,210,838.
Regarding the overall capital structure of Gland Pharma Ltd, the company's equity share capital remained stable, reported as 164,756,423 both before and after the transaction. The total diluted share/voting capital of the company after the sale was recorded at 165,562,482.
GLAND Stock Price Movement
Today, Gland Pharma Limited saw its shares climb, settling at ₹2488.3 after rising 0.59% from the previous close. The stock traded intraday within a range defined by a low of ₹2457 and a high of ₹2514.6.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.